Symptoms & Diagnosis
Symptoms & Diagnosis of Atypical Parkinsonism
Key Red Flags vs. Idiopathic Parkinson’s Disease (PD)
The presence of these features early in the disease course strongly suggests atypical parkinsonism rather than typical PD:
Current Diagnostic Criteria
Progressive Supranuclear Palsy (PSP)
MDS-PSP Criteria (2017)
Probable PSP-Richardson’s syndrome requires:
• Vertical supranuclear gaze palsy
• Postural instability with falls within 3 years
Corticobasal Degeneration (CBD)
Armstrong et al. Criteria (2013)
Probable CBD includes asymmetric rigidity + at least two of:
• Limb apraxia
• Cortical sensory deficit
• Alien limb phenomenon
Multiple System Atrophy (MSA)
Gilman et al. Criteria (2008, 2nd consensus)
Probable MSA: Autonomic failure + poorly levodopa-responsive parkinsonism or cerebellar ataxia
Role of MRI and Emerging Biomarkers
Classic MRI Findings
- PSP: Midbrain atrophy → “Hummingbird” or “penguin” sign, “morning glory” sign, superior cerebellar peduncle atrophy
- MSA-P: Putaminal atrophy, slit-like marginal hyperintensity (“putaminal rim” sign)
- MSA-C: “Hot cross bun” sign in pons, middle cerebellar peduncle atrophy
- CBD: Asymmetric peri-Rolandic cortical atrophy
Emerging Diagnostic Tools
- Alpha-synuclein seed amplification assays (αSyn-SAA) – highly accurate for MSA and DLB
- RT-QuIC in skin/nerves for MSA
- Neurofilament light chain (NfL) in blood/CSF – marker of progression
- DaTSCAN: Normal or symmetric reduction (vs. asymmetric in PD)
- Tau PET ligands under investigation for PSP and CBD